Decrease in hepatic cytochrome P-450 and catalase following allylisopropyl acetamide: the effect of concomitant hemin administration.
D000624:5-Aminolevulinate Synthetase / Q000096:biosynthesis; D000081:Acetamides / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000498:Allyl Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D001205:Ascorbic Acid / Q000652:urine; D002247:Carbon Isotopes; D002374:Catalase / Q000378:metabolism*; D004790:Enzyme Induction; D006418:Heme / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008862:Microsomes, Liver / Q000187:drug effects*; D009963:Orotic Acid / Q000378:metabolism; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D014316:Tritium; D014503:Urate Oxidase / Q000378:metabolism
D000081:Acetamides; D000498:Allyl Compounds; D000577:Amides; D002247:Carbon Isotopes; D014316:Tritium; D006418:Heme; D009963:Orotic Acid; D012313:RNA; D002374:Catalase; D014503:Urate Oxidase; D000624:5-Aminolevulinate Synthetase; D007930:Leucine; D001205:Ascorbic Acid